This article discusses the risk and opportunities of six major constituents of PJP ETF: Pfizer, Amgen, Gilead, AbbVie, BMY, ...

Gilead Sciences, Inc. (NASDAQ:GILD), a biopharmaceutical company, discovers, develops and commercializes medicines to address ...

GILD has put up a steady performance in 2024, with a new drug approval, positive data readouts and strong quarterly results.

This issue highlights a broader concern regarding medication coverage and affordable health care. It underscores the critical ...

Keytruda maintains top sales in global drug market as diabetes drugs gain ground Keytruda leads sales as metabolic disease ...

Mercks Keytruda tops global pharmaceutical sales as Humira drops out of top 10 Mercks cancer drug dominates global sales ...

The dispute centred around Gilead's triple-drug regimen Biktarvy, which is based on emtricitabine, tenofovir alafenamide and integrase inhibitor bictegravir. ViiV claimed the latter compound ...

In a phase 2 trial, an antiretroviral combination developed by Gilead Sciences and MSD suppressed HIV with a single weekly oral dose, raising the hope of a new treatment option for patients.

Merck MRK announced positive topline data from two pivotal phase III studies evaluating the investigational, once-daily, oral ...

Humans aren't alone when it comes to yawning — all vertebrates do it too, including fish, amphibians, reptiles, birds and mammals. But why? The "evolutionarily ancient" act of yawning likely ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...